Access Pharmaceuticals, Inc.
| OTC Markets: ACCP
Access Pharmaceuticals, Inc. is an emerging pharmaceutical company engaged in the development of novel therapeutics for the treatment of cancer and supportive care of cancer patients. It is focused on developing a range of pharmaceutical and medical device products primarily based upon nanopolymer chemistry technologies and other drug delivery technologies. The company's products are MuGard, ProLindac, Cobalamin, Thiarabine, CobOral and CobaCyte. The company was founded in 1974 and is headquartered in Dallas, TX.